Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
The EHA2026 Congress brings together healthcare professionals, researchers and scientists from across the global haematology community for several days of education, research updates and professional exchange.
The congress taking place in Stockholm, Sweden and online, covers the full spectrum of haematology, with a programme designed to support clinical practice, translational research and scientific collaboration across malignant and non-malignant blood disorders.
Scientific programme and educational content
Latest research findings in haematological malignancies and benign haematology.
Updates in diagnostics, genomics and translational science.
Advances in treatment approaches, including cellular treatment and transplant.
Educational sessions supporting clinical decision-making and best practice.
Opportunities to engage with emerging data and international experts.
Sessions are delivered through a mix of plenary lectures, oral presentations, poster sessions and interactive formats.
Who should attend
The congress is relevant for healthcare professionals working in haematology, including consultant haematologists, specialty registrars, researchers, nurses, pharmacists and allied healthcare professionals involved in haematology care and research.
Why attend
EHA2026 offers an opportunity to stay up to date with international haematology research, explore developments shaping future practice, and connect with peers across Europe and beyond.
–
